ClemeƱa, Ruvelyn .
HRN: 27-99-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2026
CEFUROXIME 500MG (TAB)
04/26/2026
05/03/2026
ORAL
500mg
BID
S/P Pelvic Laparotomy
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: